Corpus callosum thickness and area in Parkinson’s disease
Objective: To evaluate corpus callosum thickness and area in Parkinson's disease (PD) subjects and the relationship of these measures with cognitive impairment. Background: Many PD…Diffusion tensor metrics of thalamic degeneration and postural instability in Parkinson’s disease
Objective: The purpose of our study was to assess the relationship of diffusion tensor imaging (DTI) metrics and motor outcomes, with a specific emphasis on…Presenting symptoms and cognitive profile in Lewy body dementia: A series of cases
Objective: The study aim is to outline the Lewy body dementia (DLB) phenotypes as presenting symptoms and its correlation with cognitive profiles and clinical evolution…Cognitive profile of Filipino patients with X-linked dystonia parkinsonism
Objective: This study aims to provide a quantitative and qualitative description of the neuropsychological profile of patients diagnosed with X-linked dystonia-parkinsonism (XDP) given in a…Screening of posterior cortical dysfunction in early Parkinson’s disease with mild cognitive impairment as an approach to select patients at higher risk for developing dementia
Objective: Based on the importance of progressive dysfunction of posterior cortical regions in cognitive deterioration in PD, we explored whether posterior cortical dysfunction in early…Rapid eye movement sleep behavior disorder symptoms correlate with domains of cognitive impairment in Parkinson’s disease
Objective: To investigate (1) the domains of cognitive impairment in patients with Parkinson's disease (PD) and rapid eye movement sleep behavior disorder (RBD). (2) To…Dyskinesias-reduced-self-awareness and theory of mind in Parkinson’s disease: A novel frame of interpretation
Objective: To analyze the existence of a relationship between Dyskinesias-reduced-self-awareness (DRSA) and abilities related to cognitive and affective Theory of Mind (ToM), which may represent…Transcranial sonography and cognitive dysfunction in Parkinson’s disease
Objective: To evaluate the role of transcranial sonography (TCS) in discriminating between Parkinson's disease (PD) patients with normal cognition (PDNC), mild cognitive impairment (PD-MCI) and…Cognition and amyloid biomarker status in non-demented patients with Parkinson’s disease patients (PD) with or without subjective cognitive decline (SCD)
Objective: To compare the cognitive and Amyloid-beta 1-42 profile of non-demented Parkinson's disease patients (PD) reporting subjective cognitive decline (SCD) with or without concerns regarding…Construct validity of Moca test in a sample of patients with Parkinson´s disease in Bogotá and Cali – Colombia
Objective: To evaluate of construct validity for a sample of patients with PD in Bogotá and Cali - Colombia. Background: Parkinson´s disease (PD) is a…
- « Previous Page
- 1
- …
- 113
- 114
- 115
- 116
- 117
- …
- 207
- Next Page »